![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
Protocol
IDs
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Hemato INCAN 01/2007
NCT00429065
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
2006-00055-18
NCT00415103
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Levosta-CBF-02/04
NCT00215007
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
GC P#02.01.001
NCT00469729
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
RPCI-I-72806
I 72806, NCT00536601
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
EORTC-58951
NCT00003728
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
FRE-IGR-ALCL99
EU-20031, NHL2000/06, NCT00006455
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Total-Body Irradiation With Or Without Fludarabine Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
FHCRC-1813.00
5666, NCT00075478
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
HLMCC-0402
NCT00369564, ACCL 0731
![](https://webarchive.library.unt.edu/eot2008/20090201145020im_/http://www.cancer.gov/images/spacer.gif)
|
|